Jefferies Financial Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,529
Closed -$807K 1432
2024
Q1
$807K Hold
31,529
0.01% 898
2023
Q4
$870K Sell
31,529
-5,116
-14% -$312K 0.01% 1016
2023
Q3
$2.23M Buy
36,645
+35,072
+2,230% +$2.46M 0.02% 591
2023
Q2
$103K Buy
+1,573
New +$115K ﹤0.01% 1509

Other funds holding BLUE

Jefferies Financial Group's BLUE Position: Q2 2024 in Review

Jefferies Financial Group sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 31,529 shares — an estimated $807K sold.

Jefferies Financial Group first reported a position in BLUE in Q2 2023 and held it in 4 quarters. The position peaked at $2.23M in Q3 2023. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • Jefferies Financial Group reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 31,529 bluebird bio shares in Q2 2024, an estimated $807K.
  • Jefferies Financial Group first reported a position in bluebird bio in Q2 2023 and held it in 4 quarters.
  • Jefferies Financial Group's bluebird bio position peaked at $2.23M in Q3 2023.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.